Charles N York II's Net Worth

Charles N York II's net worth is estimated to be at least $1,514,512.71 as of 02/02/2023. CoreStreet's estimation of Charles N York II's net worth is based on their sale of stock and current holding of stock.

Charles N York II is CFO at Day One Biopharmaceuticals Inc. They have executed at least 13 trades of stock as per SEC Form 4 filings. Their most recent trade was for 10,000 units of DAWN stock on 01/20/2023. Their biggest sale was on 01/20/2023 when they sold 10,000 units of Day One Biopharmaceuticals Inc stock for $227,500.00. They typically trade 4 times per year.

Total value of insider buys:
  • $146,131.32
Total value of insider sells:
  • $1,368,381.39
Most recent insider trade:
  • Jan. 20, 2023

Charles N York II's Insider Trading History

Day One Biopharmaceuticals IncTitleAmountPriceTypeTotal Value
Jan. 20, 2023
CFO10,000$22.75Sell$227,500.00
Dec. 20, 2022
CFO10,000$20.07Sell$200,700.00
Nov. 21, 2022
CFO10,000$20.76Sell$207,600.00
Nov. 16, 2022
CFO430$21.46Sell$9,227.80
Nov. 1, 2022
CFO10,000$20.03Sell$200,300.00
Oct. 3, 2022
CFO10,000$20.05Sell$200,500.00
Aug. 16, 2022
CFO1,089$24.31Sell$26,473.59
Aug. 4, 2022
CFO10,000$20.05Sell$200,500.00
July 18, 2022
CFO2,500$20.00Sell$50,000.00
July 5, 2022
CFO800$20.00Sell$16,000.00
July 1, 2022
CFO1,479$20.00Sell$29,580.00
Aeglea Bio Therapeutics IncTitleAmountPriceTypeTotal Value
Dec. 5, 2017
CFO25,959$4.48Buy$116,296.32
Dec. 1, 2017
CFO6,500$4.59Buy$29,835.00